Strengthening Dollar Selling Pressure Keeps Bitcoin Bearish
Bitcoin weakens as the dollar strengthens, signaling tighter liquidity and renewed selling pressure. Analysts warn th...
Which Cash Back Credit Cards Have No Annual Fee
Find out which cash back credit cards have no annual fee to suit your spending habits. Discover the perfect card for you today!
27,937 articlesPrice Prediction: Figma Stock Could Double This Year
Investors are eyeing a potential rebound for Figma as enterprise adoption grows and AI-driven updates sharpen the pla...
Bitcoin Slumps to $71,500 as Geopolitical Heat Roils
Bitcoin tumbled to the low $71,000s on June 1, 2026, as geopolitical tensions sparked a wave of liquidations across c...
Cramer Sees Tech Rebound as Oracle Upside Emerges
Tech stocks regain momentum as data-center spending reshapes the market. Oracle stands out as a potential upside surp...
Warren Buffett’s Final Investment Signals Full Circle
As Berkshire transitions to Greg Abel, Warren Buffett’s final investment points to a return to era-defining brands. T...
Microsoft Held Chips Sold: Safer Megacap AI Bet Now?
As AI enthusiasm shakes up the tech market, Microsoft stands out as a potentially steadier megacap. This article brea...
Apple Just Raised Prices: The AI Stock Winner Today
Apple's latest price move spotlights a broader trend: AI-driven demand for memory chips. This piece explains how the ...
Marvell Drops Capex Slowdown as AI Chip Rally Slips
Marvell Technology tumbles on revised AI capex forecasts, intensifying a wider retreat in semiconductor names. Major ...
Goldman’s Lindsay Rosner Says July Fed Hike Possible
Goldman’s Lindsay Rosner says July rate hikes are on the table as inflation and energy prices keep Fed expectations a...
Seven REIT Stocks Pass Screening; Yields Reach 6.27%
Seven REITs cleared a strict financial screen, delivering dividends as high as 6.27% and drawing investor attention a...
Wall Street Analyst Thinks Pfizer Stock Could Soar 38% This Week
A single wall street analyst thinks Pfizer's stock could spark a meaningful rally. Learn the catalysts, risks, and ho...
Teva's Biosimilar Boom Just Beginnings: Is It Time to Buy?
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status